Document is current
Any future updates will be listed below
-
Authors
Fienemann, André https://orcid.org/0009-0004-9594-3673
Prietzsche, Julia C.
Laβ, Joshua
Much, Christoph
Schaake, Susen
Lüth, Theresa
Gabbert, Carolin
Zimprich, Alexander
Stögmann, Elisabeth https://orcid.org/0000-0003-4688-8482
König, Theresa
Ganos, Christos
Gül-Demirkale, Tuğçe https://orcid.org/0000-0002-1818-9839
Başak, A. Nazlı https://orcid.org/0000-0001-6977-2517
Jamora, Roland Dominic G. https://orcid.org/0000-0001-5317-7369
Rosales, Raymond L.
Saranza, Gerard https://orcid.org/0000-0001-8322-4226
Diesta, Cid Czarina E.
Möller, Meret
Borsche, Max
Kleinz, Teresa https://orcid.org/0009-0000-6313-7395
Balck, Alexander https://orcid.org/0000-0003-3967-0282
Brüggemann, Norbert https://orcid.org/0000-0001-5969-6899
Seibler, Philip https://orcid.org/0000-0002-3496-7194
Klein, Christine
Trinh, Joanne
-
Funding
Funding for this research was provided by:
services and facilities of the Koç University Research Center for Translational Medicine
Wolf Chair for Neurodevelopmental Psychiatry, a joint Hospital-University Named Chair between the University of Toronto, UHN, and the UHN Foundation
honoraria for educative activities by the International Movement Disorder Society and Merz Pharmaceuticals
Global Parkinson's Genetics Program (GP2) funded by the Aligning Science Across Parkinson's initiative and implemented by The Michael J. Fox Foundation
Deutsche Forschungsgemeinschaft (TR 1714/4-1)
- License Information
-
More Information
Article History
Received: 7 January 2026
Accepted: 12 September 2026
First Online: 24 September 2026
Declarations
Competing interests: The authors declare the following competing interests: RDGJ has received travel grants and speakers’ honoraria from Royal Care Super Specialty Hospital, Darya-Varya Laboratoria, and the Philippine offices of AbbVie, Exeltis, HI-Eisai, Innogen, Medichem, Natrapharm, Sun, Torrent, and Vexxa. M.B. received honoraria from Bial Germany. N.B. received honoraria from AbbVie, Esteve, Ipsen, Merz, Takeda, Teva, and Zambon. J.T. has received travel funding to speak on behalf of O.N.T. C.K. has served as a medical advisor to Centogene, Takeda, and Biogen and received speakers’ honoraria from Bial, as well as royalties from Oxford University Press and Springer Nature. The other authors do not have a competing interest.
